With 3.86 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.67 million shares. The 52-week range on MYGN shows that it touched its highest point at $29.30 and its lowest point at $3.98 during that stretch. It currently has a 1-year price target of $9.50. Beta for the stock currently stands at 2.03.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MYGN was down-trending over the past week, with a drop of -48.54%, but this was down by -53.96% over a month. Three-month performance dropped to -68.65% while six-month performance fell -77.91%. The stock lost -80.33% in the past year, while it has lost -71.63% so far this year. A look at the trailing 12-month EPS for MYGN yields -1.12 with Next year EPS estimates of 0.16. For the next quarter, that number is -0.00. This implies an EPS growth rate of -91.01% for this year and 1178.06% for next year.
Float and Shares Shorts:
At present, 92.20 million MYGN shares are outstanding with a float of 87.74 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MYGN since 7 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 5 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.15234 being high and $0.12187 being low. For MYGN, this leads to a yearly average estimate of $0.13203.
